Published in Cells on December 06, 2013
Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer (2015) 2.00
Hallmarks of glycosylation in cancer. Oncotarget (2016) 0.86
A role for Galgt1 in skeletal muscle regeneration. Skelet Muscle (2015) 0.78
Neuraminidase-1 contributes significantly to the degradation of neuronal B-series gangliosides but not to the bypass of the catabolic block in Tay-Sachs mouse models. Mol Genet Metab Rep (2015) 0.75
Lipid microdomain modification sustains neuronal viability in models of Alzheimer's disease. Acta Neuropathol Commun (2016) 0.75
Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and Cancer. Cells (2016) 0.75
Cell signaling by receptor tyrosine kinases. Cell (2010) 12.39
Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci U S A (2003) 2.56
The glycosynapse. Proc Natl Acad Sci U S A (2002) 2.46
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet (2004) 2.45
A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A (1999) 2.05
Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem (2001) 2.04
Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem (1986) 2.00
Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta (2007) 1.86
Glycan microarrays for decoding the glycome. Annu Rev Biochem (2011) 1.81
Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci U S A (2007) 1.79
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79
Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell (2012) 1.79
Functional role of glycosphingolipids in cell recognition and signaling. J Biochem (1995) 1.75
Crosstalk in Met receptor oncogenesis. Trends Cell Biol (2009) 1.70
Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review. J Lipid Res (2008) 1.68
Regulation of human EGF receptor by lipids. Proc Natl Acad Sci U S A (2011) 1.64
Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes. J Biol Chem (2008) 1.55
Regulation of growth factor receptors by gangliosides. Sci STKE (2002) 1.54
Role of tumor-associated gangliosides in cancer progression. Biochimie (2003) 1.51
Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci U S A (2006) 1.43
Using plasma membrane nanoclusters to build better signaling circuits. Trends Cell Biol (2008) 1.41
Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem (2007) 1.40
Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc Natl Acad Sci U S A (1996) 1.37
Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. Proc Natl Acad Sci U S A (1994) 1.32
Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J Biol Chem (2005) 1.31
Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. J Biol Chem (1992) 1.29
Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J Biol Chem (2002) 1.26
Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc Natl Acad Sci U S A (1995) 1.25
Molecular cloning of brain-specific GD1alpha synthase (ST6GalNAc V) containing CAG/Glutamine repeats. J Biol Chem (1999) 1.23
TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology (2004) 1.22
The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J Neural Transm (Vienna) (2009) 1.20
Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci U S A (2008) 1.17
A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family. J Biol Chem (1998) 1.10
Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13. J Biol Chem (2004) 1.08
Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase. J Biol Chem (1998) 1.05
Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J Biol Chem (2004) 1.04
Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions. J Biol Chem (2009) 1.03
Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. J Biol Chem (2004) 1.03
Overexpression of plasma membrane-associated sialidase attenuates insulin signaling in transgenic mice. J Biol Chem (2003) 1.03
A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. J Biol Chem (1988) 1.01
GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J Neurochem (2002) 0.99
Overexpression of ganglioside GM1 results in the dispersion of platelet-derived growth factor receptor from glycolipid-enriched microdomains and in the suppression of cell growth signals. J Biol Chem (2002) 0.99
Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling. Cancer Res (2006) 0.99
GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J Biol Chem (1994) 0.99
Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B. Cell Prolif (2002) 0.97
Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues. Proc Natl Acad Sci U S A (2009) 0.97
Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology (1996) 0.96
Organization of ganglioside synthesis in the Golgi apparatus. Biochim Biophys Acta (1999) 0.95
Purification, cDNA cloning, and expression of UDP-Gal: glucosylceramide beta-1,4-galactosyltransferase from rat brain. J Biol Chem (1998) 0.95
Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2. Glycobiology (2008) 0.95
Ganglioside designation. Adv Exp Med Biol (1980) 0.93
Metabolically incorporated photocrosslinking sialic acid covalently captures a ganglioside-protein complex. Mol Biosyst (2010) 0.92
GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells. Biol Chem (2009) 0.91
Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J Biomed Biotechnol (2010) 0.90
Modulation of epidermal growth factor receptor phosphorylation by endogenously expressed gangliosides. Biochem J (2001) 0.89
O-acetylation of GD3 prevents its apoptotic effect and promotes survival of lymphoblasts in childhood acute lymphoblastic leukaemia. J Cell Biochem (2008) 0.89
Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Exp Cell Res (2000) 0.89
Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration. Biochem Biophys Res Commun (2001) 0.88
Expression cloning of mouse cDNA of CMP-NeuAc:Lactosylceramide alpha2,3-sialyltransferase, an enzyme that initiates the synthesis of gangliosides. J Biol Chem (1999) 0.88
Gangliosides enhance apoptosis of thymocytes. Cell Immunol (1998) 0.88
Expression cloning of a human GT3 synthase. GD3 AND GT3 are synthesized by a single enzyme. J Biol Chem (1996) 0.88
GD3 synthase gene expression in PC12 cells results in the continuous activation of TrkA and ERK1/2 and enhanced proliferation. J Biol Chem (2000) 0.87
Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells. J Neurochem (1995) 0.87
The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase. Glycobiology (2012) 0.86
The Csk-binding protein PAG regulates PDGF-induced Src mitogenic signaling via GM1. J Cell Biol (2008) 0.86
Molecular cloning and expression of human ST6GalNAc III: restricted tissue distribution and substrate specificity. J Biochem (2005) 0.86
Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells. J Neurochem (1993) 0.85
Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma. J Neurochem (2006) 0.85
Biosynthesis of the major brain gangliosides GD1a and GT1b. Glycobiology (2012) 0.85
Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice. Metabolism (2007) 0.85
Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells. Carbohydr Res (2009) 0.84
GM1 ganglioside activates the high-affinity nerve growth factor receptor trkA. J Neurochem (1995) 0.84
Modulation of growth factor signaling by gangliosides: positive or negative? Methods Enzymol (2006) 0.84
Ganglioside modulation of the PDGF receptor. A model for ganglioside functions. J Neurooncol (1995) 0.83
Inhibition of ganglioside GD1a synthesis suppresses the differentiation of human mesenchymal stem cells into osteoblasts. Dev Growth Differ (2011) 0.83
GD₃ synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activation. Mol Cancer Res (2010) 0.83
Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway. Int J Biochem Cell Biol (2013) 0.82
Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway. J Cell Biochem (2013) 0.82
Regulation of epidermal growth factor receptor through interaction of ganglioside GM3 with GlcNAc of N-linked glycan of the receptor: demonstration in ldlD cells. Neurochem Res (2011) 0.81
Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer. J Oncol (2010) 0.81
Cloning and transcriptional regulation of genes responsible for synthesis of gangliosides. Curr Drug Targets (2008) 0.81
Cloning and expression of cDNA for a human Gal(beta1-3)GalNAc alpha2,3-sialyltransferase from the CEM T-cell line. Eur J Biochem (1997) 0.80
cDNA cloning and expression of human lactosylceramide synthase. Biochim Biophys Acta (1999) 0.80
Gangliosides as receptor modulators. Adv Exp Med Biol (1984) 0.80
Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase. Molecules (2012) 0.80
Regulation of ganglioside metabolism by phosphorylation and dephosphorylation. J Neurochem (1998) 0.80
Substrate specificity of beta 1,4-N-acetylgalactosaminyltransferase in vitro and in cDNA-transfected cells. GM2/GD2 synthase efficiently generates asialo-GM2 in certain cells. J Biol Chem (1995) 0.79
GM1-induced activation of phosphatidylinositol 3-kinase: involvement of Trk receptors. J Neurochem (2007) 0.79
Differential modulation of basic fibroblast and epidermal growth factor receptor activation by ganglioside GM3 in cultured retinal Müller glia. Glia (1996) 0.79
GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells. Anticancer Res (2000) 0.78
Dissociation of the insulin receptor from caveolae during TNFα-induced insulin resistance and its recovery by D-PDMP. FEBS Lett (2011) 0.77
Molecular cloning and expression of human alpha2,8-sialyltransferase (hST8Sia V). Biochem Biophys Res Commun (1997) 0.77
Domain-dependent modulation of PDGFRbeta by ganglioside GM1. J Mol Neurosci (2003) 0.77
The c-series gangliosides GT3, GT2 and GP1c are formed in rat liver Golgi by the same set of glycosyltransferases that catalyse the biosynthesis of asialo-, a- and b-series gangliosides. Glycobiology (1992) 0.77
Regulation of glycosyltransferases in ganglioside biosynthesis by phosphorylation and dephosphorylation. Mol Cell Endocrinol (2001) 0.77
Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met. Int J Cancer (2001) 0.76
Rapid and sensitive MRM-based mass spectrometry approach for systematically exploring ganglioside-protein interactions. Proteomics (2013) 0.76
Anti-GM3 antibodies activate calcium inflow and inhibit platelet-derived growth factor beta receptors (PDGFbetar) in T51B rat liver epithelial cells. Glycobiology (1998) 0.76
Sialyl-tn in cancer: (how) did we miss the target? Biomolecules (2012) 0.84